{"transactions":[{"id":1020677,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2025-10-09T08:47:29.000Z","date":"2025-10-08","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":17.58,"expiration_date":"2035-10-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-25-235248","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682419/000119312525235248/ownership.xml","form_type":"4"}},{"id":1327912,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-12-17T17:13:03.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.5045,"expiration_date":"2034-12-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-24-137369","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682419/000095017024137369/ownership.xml","form_type":"4"}},{"id":1383948,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-18T09:14:55.000Z","date":"2024-10-17","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.9496,"value":18992.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase by the reporting person of 20,000 shares of common stock, par value $0.0001 per share (the \"Common Stock\"). The number of shares of Common Stock reported represents an aggregate number of shares purchased in multiple open market transactions over a range of sales prices."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on October 17, 2024 at prices ranging from $0.9479 to $0.9497 per share, inclusive. The amount reflected has been rounded to four decimal points. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0000950170-24-115452","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682419/000095017024115452/ownership.xml","form_type":"4"}},{"id":1472736,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-06-20T18:07:26.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was October 4, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":245000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-10-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-24-075773","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682419/000095017024075773/ownership.xml","form_type":"4"}},{"id":1472735,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T18:07:26.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":1.41,"value":7050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"1/48th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was October 4, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000950170-24-075773","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682419/000095017024075773/ownership.xml","form_type":"4"}},{"id":1764190,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-10-05T21:26:38.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-10-04","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000950170-23-052256","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682419/000095017023052256/ownership.xml","form_type":"4"}},{"id":2255980,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-26T16:13:08.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":388387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option award will vest ratably quarterly to the end of the year."}],"balance_after":388387,"derivative":{"exercise_price":0.4664,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":388387},"source":{"system":"sec-edgar","filing":"0001104659-22-065267","document":"tm2214964d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000110465922065267/tm2214964d3_4.xml","form_type":"4"}},{"id":2587352,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-08-30T20:16:20.000Z","date":"2021-08-30","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the original number of shares subject to this option shall vest and become exercisable on September 30, 2021, and 1/48th of the original number of shares subject to the option shall vest following each one month of service thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":8.86,"expiration_date":"2031-08-30","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-21-053986","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919121053986/doc4.xml","form_type":"4"}},{"id":2667069,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T16:02:38.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":110459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Stock option award will vest ratably quarterly to the end of the year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option award will vest ratably quarterly to the end of the year."}],"balance_after":110459,"derivative":{"exercise_price":1.65,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":110459},"source":{"system":"sec-edgar","filing":"0001104659-21-081995","document":"tm2119809d5_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000110465921081995/tm2119809d5_4.xml","form_type":"4"}},{"id":3105972,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-18T06:04:36.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":68800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option award will vest ratably quarterly to the end of the year."}],"balance_after":68800,"derivative":{"exercise_price":2.63,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":68800},"source":{"system":"sec-edgar","filing":"0001104659-20-074352","document":"tm2022841d3_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000110465920074352/tm2022841d3_form4.xml","form_type":"4"}},{"id":3111129,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-06-15T18:09:09.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the original number of shares subject to this option shall vest and become exercisable on July 15, 2020, and 1/12th of the original number of shares subject to the option shall vest following each one month of service thereafter, subject to the Reporting Person's continued service on the Issuer's board of directors on each such date."}],"balance_after":100000,"derivative":{"exercise_price":4.89,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000850261-20-000042","document":"wf-form4_159225892982664.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000085026120000042/wf-form4_159225892982664.xml","form_type":"4"}},{"id":3481836,"issuer":{"id":123920,"kind":"organization","name":"CASI Pharmaceuticals, Inc.","symbol":"CASI"},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T17:01:22.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":57885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Stock option award will vest ratably quarterly to the end of the year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option award will vest ratably quarterly to the end of the year."}],"balance_after":57885,"derivative":{"exercise_price":3.13,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":57885},"source":{"system":"sec-edgar","filing":"0001144204-19-031920","document":"tv524058_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895051/000114420419031920/tv524058_4.xml","form_type":"4"}},{"id":3551254,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-04-23T21:00:17.000Z","date":"2019-04-19","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of the original number of shares subject to this option shall vest and become exercisable on May 14, 2019 and following each one month of service thereafter, subject to the Reporting Person's continued service on the Issuer's board of directors on each such date."}],"balance_after":70000,"derivative":{"exercise_price":3.78,"expiration_date":"2029-04-19","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0000850261-19-000011","document":"wf-form4_155606760258733.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000085026119000011/wf-form4_155606760258733.xml","form_type":"4"}},{"id":3752512,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-11-27T19:48:47.000Z","date":"2018-11-26","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of the original number of shares subject to this option shall vest and become exercisable following each one month of service thereafter, subject to the Reporting Person's continued service on the Issuer's board of directors on each such date."}],"balance_after":35000,"derivative":{"exercise_price":3.57,"expiration_date":"2028-11-26","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000850261-18-000045","document":"wf-form4_154336611152477.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000085026118000045/wf-form4_154336611152477.xml","form_type":"4"}},{"id":4207694,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-09-18T06:20:08.000Z","date":"2017-09-15","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This amended report on Form 4 is being filed to amend the Form 4 filed by the reporting person on September 15, 2017 to correct the exercise price, which was inadvertently reported as $1.75."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12 of the original number of shares subject to this option shall vest and become exercisable following each one month of service thereafter, subject to the reporting person's continued service on the issuer's board of directors on each such date."}],"balance_after":35000,"derivative":{"exercise_price":1.8,"expiration_date":"2027-09-15","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001144204-17-048378","document":"v475339_4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000114420417048378/v475339_4a.xml","form_type":"4/A","original_submission_date":"2017-09-15"}},{"id":4208814,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-09-15T21:44:03.000Z","date":"2017-09-15","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of the original number of shares subject to this option shall vest and become exercisable following each one month of service thereafter, subject to the reporting person's continued service on the issuer's board of directors on each such date."}],"balance_after":35000,"derivative":{"exercise_price":1.75,"expiration_date":"2027-09-15","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001144204-17-048357","document":"v475323_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000114420417048357/v475323_4.xml","form_type":"4"}},{"id":4469969,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":74378,"kind":"person","name":"Wu Yue Alexander","position":1,"cik":"0001682419","reported_name":"Wu Yue Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-03T19:51:43.000Z","date":"2017-02-03","kind":"purchase","acquired":true,"shares":5000,"price":5.15,"value":25750.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000899243-17-002791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000089924317002791/doc4.xml","form_type":"4"}}]}